Bill > HB1296

This bill establishes a three-year pilot program, called the Breakthrough Treatments for Georgia Heroes Suicide Prevention Pilot Program, to support clinical research and provide certain eligible breakthrough treatments to veterans and retired first responders suffering from conditions like post-traumatic stress disorder, treatment-resistant depression, and traumatic brain injury. An "eligible breakthrough treatment" is defined as specific medical devices or drugs that have received "breakthrough designation" or "breakthrough therapy designation" from the U.S. Food and Drug Administration (FDA), or treatments like Ibogaine and transcranial magnetic stimulation, or similar investigational or approved treatments. The program, which will be implemented by the department (referring to the Georgia Department of Behavioral Health and Developmental Disabilities, though not explicitly named in this excerpt), can use funds to establish research sites, conduct clinical trials to support FDA approval of treatments, subsidize treatment costs, invest in clinical infrastructure, provide workforce training, and develop treatment guidelines. The department is authorized to partner with research institutions and accept grants. An annual report on the program's implementation and effectiveness will be submitted to state officials, and the program is set to terminate on January 1, 2030, with this bill becoming effective only if funds are specifically appropriated by the General Assembly.

Military Affairs and Security

https://www.legis.ga.gov/legislation/73173